Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBFM · Dec 31, 2021
Sunshine Biopharma Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001683168-22-001788General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-800.75% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
219.88% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
46.25% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
48.42% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-1068.24% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
294.28% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History30 statesSelf-history eligible
Dec 31, 20214/7 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/7 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/7 normalizedLevel 3Dec 31, 20236/7 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedAmended as filedSep 30, 20246/6 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -1192.65%
- Current
- -800.75%
- Delta
- 391.89%
- Previous
- 193.74%
- Current
- 219.88%
- Delta
- 26.14%
- Previous
- 141.56%
- Current
- 46.25%
- Delta
- -95.30%
- Previous
- 61.28%
- Current
- 48.42%
- Delta
- -12.86%
- Previous
- -985.11%
- Current
- -1068.24%
- Delta
- -83.13%
- Previous
- 441.61%
- Current
- 294.28%
- Delta
- -147.33%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · SBFM Fundamental State →Transitioned To · SBFM Fundamental State →Transitioned To · SBFM CASH_GENERATION_INCREASED →Transitioned To · SBFM GROWTH_INCREASED →Transitioned To · SBFM INVENTORY_PRESSURE_DECREASED →Transitioned To · SBFM MARGIN_DECREASED →Transitioned To · SBFM PROFITABILITY_DECREASED →Transitioned To · SBFM R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.